한빛사논문 | BRIC

김성준 님의 논문 목록

H. Lee Moffitt Cancer Center & Research Institute

- 김성준(H. Lee Moffitt Cancer Center & Research Institute)
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
- Lancet, 2022 Sep 24;400(10357):1008-1019 | https://doi.org/10.1016/S0140-6736(22)01659-2
- 2022-09
- 한빛사논문
- 김성준(H. Lee Moffitt Cancer Center & Research Institute)
Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells
- Cell Metab., Available online 7 August 2020 | https://doi.org/10.1016/j.cmet.2020.07.008
- 2020-08
- 한빛사논문
- 김성준(H. Lee Moffitt Cancer Center & Research Institute)
Methylation of immune synapse genes modulates tumor immunogenicity
- J. Clin. Invest., February 3, 2020, 130(2):974-980 | https://doi.org/10.1172/JCI131234
- 2020-02
- 한빛사논문
- 김성준(Vanderbilt University School of Medicine)
  Interview
Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice
- J. Clin. Invest., doi:10.1172/JCI33071
- 2008-04
- 한빛사논문

저자논문